Lisa L retweeted
The ADC landscape is moving fast! Don't get left behind. Join Beth Sandy, MSN, CRNP, FAPO, Jamie Carroll, APRN, CNP, MSN, and Jaclyn Shaver, MS, APRN, CNP, WHNP in Minneapolis or virtually on Friday, 10/16 at 7:15 PM CDT: bit.ly/ADCTumors26-T
#JADPROLive2026 #ADCs #Oncology
Lisa L retweeted
@PeerView @myESMO Excited to participate in this panel with Drs. VanCustem and Saw talking about all things HER2 in solid tumors. Join us virtually or in Madrid.
Leveraging HER2-Targeted ADCs in Solid Tumours: Hear the latest practice-changing data supporting the use of HER2-targeted ADCs in the treatment of solid tumours with Drs. Moore (@DrKatyMoore), Saw (@stephanieplsaw), and Van Cutsem in #SolidTumours 📍10/26 at at 18:15 PM CET: bit.ly/MadridADC26-T #ESMO2026 #Oncology
Lisa L retweeted
Hear from Dr. Vishal Anil Patel — and join him and his co-chair @DrKhushalani for our #CSCC live virtual webcast on Tues, 9/15 at 7 PM EDT: bit.ly/CSCC26-T #Immunotherapy #MedEd
Lisa L retweeted
🔥 ATTR-CA HOT TOPICS. YOUR QUESTIONS.
Join @PeerView LIVE Sunday, 11/8 at 5:30 PM CST at #AHA #ScientificSessions26‼️
🎤 Ask questions
💬 Join the discussion
🔥 Challenge the experts, Drs. Ahmad Masri (@MasriAhmadMD), Margot Davis & Daniel Judge
🔗 bit.ly/26-ATTR-T
Lisa L retweeted
Remember to join us 9/13 at 6:00 PM KST, for our #LungCancer live in-person and virtual symposium with Drs. Liu (@StephenVLiu), Cascone & Solomon (@bensolomon1). Register now: bit.ly/Seoul26-T #Oncology #MedEd
Lisa L retweeted
From HER2 testing to HER2-directed ADCs in #NSCLC — how do you put it all together? Join Drs. Planchard (@dplanchard), Horinouchi (@HHorinouchi), and Smit 9/14 at 13:45 KST in-person & virtually: bit.ly/Seoul26HER2-T
#WCLC26 #Oncology
Lisa L retweeted
At #WCLC26, be sure to join Drs. Tina Cascone, @bensolomon1 , and me at this very timely @PeerView symposium on Sunday 9/13/26, 6pm local time in Seoul to discuss how bispecific antibodies will impact lung cancer!
Register here (in person or virtual):
lrn.peerview.com/150211777_1…
Lisa L retweeted
Excited to Discuss Rapidly Evolving Landscape of MIBC Treatment - Shilpa Gupta (@shilpaonc)
@SpeakJen
oncodaily.com/voices/shilpa-…
#OncoDaily #Oncology #Cancer #Health #Medicine
Lisa L retweeted
Next Wednesday we speak with Dr. Elisabeth Heath about the future of prostate cancer care.
Tune in from 4:00 to 5:00PM CET (10:00AM EST) at:
Barcelona Radio: 102.5FM - La Marina Cat
Internet: lamarina.cat/endirecte/
YouTube: youtube.com/@LaMarinaFMProgr…
Lisa L retweeted
Biomarker-driven care. Immunotherapy. Real-world outcomes. These aren't just buzzwords, they're what better patient care looks like.
We're joining @PeerView at #ASCO26 to bring that conversation to life.
Hear from leading experts on 5/30 at 7 PM CDT: bit.ly/2026Gastric-T
Lisa L retweeted
Don’t miss this live in person + virtual event with @PeerView! The Drs. Sagar Lonial (@SagarLonialMD), Nizar Bahlis, & Krina Patel (@DrKrinaPatel) are breaking down innovative strategies for RRMM care and the evolving role of #CELMoDs during #ASCO26.
🔗 bit.ly/2026MOD-T
Excited to partner with @PeerView to bring the MoD Squad to #ASCO26! Join Drs. @SagarLonialMD, Nizar Bahlis, & @DrKrinaPatel on 5/29 at 7 PM CDT to explore
#CELMoDs in #MultipleMyeloma.
Join us live in Chicago or virtually: bit.ly/2026MOD-T
Lisa L retweeted
Excited to discuss rapidly evolving landscape of MIBC treatment with the amazing @MattGalsky @siadaneshmand @ASCO #ASCO26 @PeerView
on Saturday, May 30
Please register
👇👇
Bladder cancer treatment is evolving fast 🚀
Join @PeerView at #ASCO26 with Drs. @MattGalsky, @siadaneshmand & @shilpaonc to:
🔬 Dive into ICIs & ADCs
🧩 Personalize treatment
🤝 Manage real-world toxicities
🗓 May 30 | 6:30 PM
Register: bit.ly/2026Bladder-T
@WorldBladderCan
Lisa L retweeted
🔥 The future of #oncology is happening now. Will you be there?
Join @PeerView at #ASCO26 for expert-led symposia covering the latest advances across solid tumors, hematologic malignancies & more‼️
💠Learn 💠Connect 💠Apply
Reserve your spot 👉 bit.ly/Oncology2026 #CME
Lisa L retweeted
Dr. Sabari (@JSabari) invites you to join him alongside Drs. Leighl & Jänne at #ASCO26 for a PeerView live symposium on EGFRm #NSCLC focused on treatment sequencing, resistance management & optimizing patient care #MedEd
📅 5/30 at 7 PM CDT
📍 Chicago + Virtual
🔗 bit.ly/2026EGFRLung-T
Lisa L retweeted
Dr. Goldman invites you to join him alongside Dr. Camidge (@DRCamidge) & Dr. Le (@LeXiuning) at #ASCO26 for a PeerView live symposium on MET-altered #NSCLC, focused on biomarker testing, MET-targeted therapies & personalized treatment strategies: bit.ly/2026METLung-T #MedEd
Lisa L retweeted
How are emerging therapies changing #HNSCC care? Join Prof. Harrington and Drs. Burtness and Bhatia (@AartiBhatiaMD) at #ASCO26 for a PeerView Live symposium on immunotherapy, bispecific antibodies, and evolving treatment strategies in HNSCC: bit.ly/2026HNC-T #MedEd @YaleCancer
Lisa L retweeted
Dr. Morgans (@CapSurvivorship) invites you to join her and Drs. Armstrong (@AarmstrongDuke) and Heath during their session, Continuing the Innovation Story in #ProstateCancer, happening during #ASCO26 on 5/29—in Chicago and virtually: bit.ly/2026Prostate-T
In partnership with Prostate Net (@vhsimons) #MedEd
Lisa L retweeted
Join Barbara Burtness, MD, and @AartiBhatiaMD at #ASCO26 for a @PeerView live symposium on advances in #HNSCC, including immunotherapy and emerging treatments in LA and R/M disease.
Join in-person in Chicago or virtually on May 29 at 7pm CDT/8pm EDT: bit.ly/2026HNC-T
@SmilowCancer
Lisa L retweeted
How are emerging therapies and biomarkers reshaping #ProstateCancer care? Join me, Drs. Heath and Morgans (@CapSurvivorship) for a @PeerView symposium during #ASCO26 on 5/29 at 7 PM CDT in Chicago or virtually. Learn more and register: bit.ly/2026Prostate-T
Lisa L retweeted
#ASCO26 is almost here—don’t miss @PeerView’s #CME symposia 🔥
Big updates across solid tumors + hematologic malignancies and more. Real-world impact. 🩺
Education at its finest 👉 Save your spot today‼️
🎟️ Register Now: bit.ly/Oncology2026